Artelo Biosciences (ARTL) EPS (Basic) Growth (1y) (2015 - 2025)
Powered by 
Analysis
Artelo Biosciences (ARTL) EPS (Basic) Growth (1y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 65.24% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -636.10% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 7.74% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -4.72% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 87.85% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 7.59% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 322.67% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -84.77% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 96.41% |
| 10 | Artelo Biosciences | 120,340.96 | -479,659.04 | - | 26.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 26.63% |
| Sep 30, 2025 | -167.36% |
| Jun 30, 2025 | -28.22% |
| Mar 31, 2025 | 9.26% |
| Dec 31, 2024 | -7.89% |
| Sep 30, 2024 | 58.24% |
| Jun 30, 2024 | -24.58% |
| Mar 31, 2024 | -0.91% |
| Dec 31, 2023 | 10.79% |
| Sep 30, 2023 | -5.27% |
| Jun 30, 2023 | 28.42% |
| Mar 31, 2023 | -19.18% |
| Nov 30, 2021 | 99.94% |
| May 31, 2021 | 64.50% |
| Feb 28, 2021 | 72.51% |
| Nov 30, 2020 | 64.69% |
| Aug 31, 2020 | 36.84% |
| May 31, 2020 | 40.02% |
| Feb 29, 2020 | -34.88% |
| Nov 30, 2019 | -67.10% |